Macular Amyloidosis Workup

1. Cai D, Li Y, Zhou C, Jiang Y, Jiao J, Wu L. Comparative proteomics analysis of primary cutaneous amyloidosis. Exp Ther Med. 2017 Oct. 14(4):3004-12. [QxMD MEDLINE Link]. [Full Text].

2. de Argila D, Ortiz-Romero PL, Ortiz-Frutos J, Rodriguez-Peralto JL, Iglesias L. Cutaneous macular amyloidosis associated with multiple endocrine neoplasia 2A. Clin Exp Dermatol. 1996 Jul. 21(4):313-4. [QxMD MEDLINE Link].

3. Fang S, Shen X, Chen AJ, Li S, Shan K. Health-related quality of life in patients with primary cutaneous amyloidosis. PLoS One. 2015. 10(3):e0120623. [QxMD MEDLINE Link]. [Full Text].

4. Errichetti E, Stinco G. Dermoscopy in general dermatology: a practical overview. Dermatol Ther (Heidelb). 2016 Dec. 6(4):471-507. [QxMD MEDLINE Link]. [Full Text].

5. Weidner T, Illing T, Elsner P. Primary localized cutaneous amyloidosis: a systematic treatment review. Am J Clin Dermatol. 2017 Oct. 18(5):629-42. [QxMD MEDLINE Link].

6. Shirahama T, Cohen AS. High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol. 1967 Jun. 33(3):679-708. [QxMD MEDLINE Link].

7. Li JJ, McAdam KP. Human amyloid P component: an elastase inhibitor. Scand J Immunol. 1984 Sep. 20(3):219-26. [QxMD MEDLINE Link].

8. Mehrotra K, Dewan R, Kumar JV, Dewan A. Primary cutaneous amyloidosis: a clinical, histopathological and immunofluorescence study. J Clin Diagn Res. 2017 Aug. 11(8):WC01-WC05. [QxMD MEDLINE Link]. [Full Text].

9. Apaydin R, Gurbuz Y, Bayramgurler D, Muezzinoglu B, Bilen N. Cytokeratin expression in lichen amyloidosus and macular amyloidosis. J Eur Acad Dermatol Venereol. 2004 May. 18(3):305-9. [QxMD MEDLINE Link].

10. Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol. 2009 Dec. 161(6):1217-24. [QxMD MEDLINE Link].

11. Qi XP, Zhao JQ, Chen ZG, et al. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D. Oncotarget. 2015 Oct 20. 6(32):33993-4003. [QxMD MEDLINE Link]. [Full Text].

12. Wali A, Liu L, Takeichi T, et al. Familial primary localized cutaneous amyloidosis results from either dominant or recessive mutations in OSMR. Acta Derm Venereol. 2015 Nov. 95(8):1005-7. [QxMD MEDLINE Link]. [Full Text].

13. Lin MW, Lee DD, Liu TT, et al. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis. Eur J Hum Genet. 2010 Jan. 18(1):26-32. [QxMD MEDLINE Link]. [Full Text].

14. Hashimoto K, Kobayashi H. Histogenesis of amyloid in the skin. Am J Dermatopathol. 1980 Summer. 2(2):165-71. [QxMD MEDLINE Link].

15. Hashimoto K, Ito K, Kumakiri M, Headington J. Nylon brush macular amyloidosis. Arch Dermatol. 1987 May. 123(5):633-7. [QxMD MEDLINE Link].

16. Yamagihara M, Kitajima Y, Yaoita H. Ultrastructural observation of the relationship between amyloid filaments and half desmosomes in macular amyloidosis [abstract]. J Cutan Pathol. 1980. 7:7:213.

17. Heng JK, Ho SA, Tan KB. Poikiloderma-like cutaneous amyloidosis--a rare presentation of primary localized cutaneous amyloidosis. Dermatol Online J. 2016 Jan 15. 22(1):[QxMD MEDLINE Link].

18. Hsieh SD, Yamamoto R, Saito K, et al. Amyloidosis presented with whitening and loss of hair which improved after dimethylsulfoxide (DMSO) treatment. Jpn J Med. 1987 Aug. 26(3):393-5. [QxMD MEDLINE Link].

19. Monfrecola G, Iandoli R, Bruno G, Martellotta D. Lichen amyloidosus: a new therapeutic approach. Acta Derm Venereol. 1985. 65(5):453-5. [QxMD MEDLINE Link].

20. Ozkaya-Bayazit E, Kavak A, Gungor H, Ozarmagan G. Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis. Int J Dermatol. 1998 Dec. 37(12):949-54. [QxMD MEDLINE Link].

21. Lim KB, Tan SH, Tan KT. Lack of effect of dimethyl sulphoxide (DMSO) on amyloid deposits in lichen amyloidosis. Br J Dermatol. 1988 Sep. 119(3):409-10. [QxMD MEDLINE Link].

22. Pandhi R, Kaur I, Kumar B. Lack of effect of dimethylsulphoxide in cutaneous amyloidosis. J Dermatolog Treat. 2002 Mar. 13(1):11-4. [QxMD MEDLINE Link].

23. Hudson LD. Macular amyloidosis: treatment with ultraviolet B. Cutis. 1986 Jul. 38(1):61-2. [QxMD MEDLINE Link].

24. Yuksek J, Sezer E, Aksu M, Erkokmaz U. Transcutaneous electrical nerve stimulation for reduction of pruritus in macular amyloidosis and lichen simplex. J Dermatol. 2011 Jun. 38(6):546-52. [QxMD MEDLINE Link].

25. Terao M, Nishida K, Murota H, Katayama I. Clinical effect of tocoretinate on lichen and macular amyloidosis. J Dermatol. 2011 Feb. 38(2):179-84. [QxMD MEDLINE Link].

26. Vestey JP, Tidman MJ, Mclaren KM. Primary nodular cutaneous amyloidosis--long-term follow-up and treatment. Clin Exp Dermatol. 1994 Mar. 19(2):159-62. [QxMD MEDLINE Link].

27. Ostovari N, Mohtasham N, Oadras MS, Malekzad F. 532-nm and 1064-nm Q-switched Nd:YAG laser therapy for reduction of pigmentation in macular amyloidosis patches. J Eur Acad Dermatol Venereol. 2008 Apr. 22(4):442-6. [QxMD MEDLINE Link]. [Full Text].

28. Khurana N, Urman C. The efficacy of Q-Switched ND:YAG 1064 nm Laser in recalcitrant macular amyloidosis: a case report. J Drugs Dermatol. 2016 Nov 1. 15(11):1456-8. [QxMD MEDLINE Link]. [Full Text].

29. Esmat SM, Fawzi MM, Gawdat HI, Ali HS, Sayed SS. Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: a randomized clinical trial. Lasers Surg Med. 2015 Jul. 47(5):388-95. [QxMD MEDLINE Link].

30. Barsky M, Buka RL. Pulsed dye laser for the treatment of macular amyloidosis: a case report. Cutis. 2014 Apr. 93(4):189-92. [QxMD MEDLINE Link].

Sultan Al-Khenaizan, MBBS, FRCPC Consulting Staff, Departments of Dermatology and Internal Medicine, King Fahad National Guard Hospital, Saudi Arabia

Disclosure: Nothing to disclose.

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Warren R Heymann, MD Head, Division of Dermatology, Professor, Department of Internal Medicine, Rutgers New Jersey Medical School

Warren R Heymann, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD<br/>Served as a speaker for various universities, dermatology societies, and dermatology departments.

Catharine Lisa Kauffman, MD, FACP Georgetown Dermatology and Georgetown Dermpath

Catharine Lisa Kauffman, MD, FACP is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Royal Society of Medicine, Society for Investigative Dermatology, Women's Dermatologic Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article